Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Treace Medical Concepts, Inc. (TMCI) had Free Cash Flow per Share of $0.01 for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
$52.57M |
|
$-15.92M |
|
$10.68M |
|
$41.89M |
|
$68.15M |
|
$-15.58M |
|
$-0.34M |
|
$-15.92M |
|
$-15.92M |
|
$-15.92M |
|
$-15.92M |
|
$-15.92M |
|
$-15.92M |
|
$-15.58M |
|
$-13.12M |
|
62.66M |
|
62.66M |
|
$-0.25 |
|
$-0.25 |
|
Balance Sheet Financials | |
$149.44M |
|
$27.13M |
|
$56.41M |
|
$205.85M |
|
$33.18M |
|
$53.38M |
|
$67.33M |
|
$100.50M |
|
$105.34M |
|
$84.69M |
|
$105.34M |
|
62.89M |
|
Cash Flow Statement Financials | |
$4.20M |
|
$-1.89M |
|
$-0.28M |
|
$11.35M |
|
$13.37M |
|
$2.02M |
|
$8.69M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
4.50 |
|
-- |
|
-- |
|
0.34 |
|
0.51 |
|
79.69% |
|
-29.64% |
|
-29.64% |
|
-- |
|
-30.29% |
|
-30.29% |
|
$0.66M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
0.28 |
|
1.69 |
|
53.26 |
|
-15.11% |
|
-18.80% |
|
-7.73% |
|
-10.03% |
|
$1.68 |
|
Free Cash Flow per Share |
$0.01 |
$0.07 |